Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.
Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare variant of HCC that most frequently affects young adults. Because of its rarity and an absence of preclinical models, our understanding of FL-HCC is limited. Our objective was to analyze chromosomal alterations and dysregulated gene expressio...
Main Authors: | Eric C Sorenson, Raya Khanin, Zubin M Bamboat, Michael J Cavnar, Teresa S Kim, Eran Sadot, Shan Zeng, Jonathan B Greer, Adrian M Seifert, Noah A Cohen, Megan H Crawley, Benjamin L Green, David S Klimstra, Ronald P DeMatteo |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5423588?pdf=render |
Similar Items
-
Mixed fibrolamellar hepatocellular carcinoma
by: Faten Limaiem, et al.
Published: (2021-06-01) -
Fibrolamellar Carcinoma: 2012 Update
by: Michael Torbenson
Published: (2012-01-01) -
Fibrolamellar liver cancer: the modern concept
by: E. Yu. Antonova, et al.
Published: (2020-12-01) -
Radiotherapy for metastatic fibrolamellar hepatocellular carcinoma
by: Justin G. Peacock, et al.
Published: (2013-07-01) -
Fibrolamellar Carcinoma: A Multimodal Approach
by: João Vasco Barreira, et al.
Published: (2020-04-01)